Where does Singular Genomics Systems, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Singular Genomics Systems, Inc. ranks #3,267 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Singular Genomics Systems, Inc. hold?

Singular Genomics Systems, Inc. holds 115 US utility patents granted between 2020 and 2025, spanning 26 technology areas.

What is Singular Genomics Systems, Inc.'s Innovation Score?

Singular Genomics Systems, Inc. has an Innovation Score of 66.2 out of 100 (top 1% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Singular Genomics Systems, Inc.'s patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for Singular Genomics Systems, Inc..

What does claim depth mean for Singular Genomics Systems, Inc.'s patents?

Singular Genomics Systems, Inc.'s patents average 19.6 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Singular Genomics Systems, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Singular Genomics Systems, Inc.

Q: What technology areas does Singular Genomics Systems, Inc. focus on?

Singular Genomics Systems, Inc.'s top technology area is C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes) with 75 patents, ranking #55 of 2,502 assignees active in that subclass. Grants appear in 26 CPC subclasses total.

USPTO PatentsView assignee record - 115 granted patents across 26 technology areas, recorded in grant years 2020–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Singular ranks #3,267 of 49,997 tracked US assignees by granted-patent volume, with 115 patents across 26 technology areas.

#3,267
of 49,997 US assignees by volume: Top 1%
by Innovation Score (66.2/100): 19.6
avg claims per patent

USPTO PatentsView assignee plate

Corpus R3267 · US Corporation #3,267 · 115 grants

GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-STRONG · CLAIMS-RICH · TYPE-USCORP · SPAN-YRS · BOOK-RICH

GRANTS-MID 115 grants
TOP-DECILE #3,267/49,997
PHOTO-FINISH Omron Automotive
CPC-FOCUS C12Q · 26 areas
INNOV-STRONG 66.2/100
CLAIMS-RICH 19.6 claims/avg
TYPE-USCORP US Corporation
SPAN-YRS 2020–2025 · 6y
BOOK-RICH 9/10 fields

Nearest grant-volume peer: Omron Automotive Electronics Co., Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Singular’s 66.2 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 16.4 pts (25%) Velocity 20.0 pts (30%) Breadth 18.0 pts (27%) Claim depth 11.8 pts (18%)

Qualcomm Incorporated · highest

85
Arista Networks · near

66
Philip Morris Products · near

66
Singular Genomics… · this assignee

66
Carl Zeiss SMT · near

66
University of… · near

66
3D Lighting… · lowest

7

What this shows Singular's Innovation Score is 66.2/100 (top 1% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Singular?

Each dot is one of Singular’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Singular’s own 19.6 claims/patent is ABOVE the 10.3 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Singular vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Singular's grants concentrate

Singular Genomics Systems, Inc. is a focused PatentsView assignee: 26 CPC subclasses with 65.2% of grants classified under C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr). Peak complete grant year is 2024 (41 grants) versus a trough of 2 in 2020. By volume, Singular sits between Omron Automotive Electronics Co., Ltd. and Asana, Inc..

Singular's three-year grant acceleration

Singular Genomics Systems, Inc. shows 81 grants in 2022–2024 against only 7 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Omron Automotive

115
Pi-design

115
Shofu

115
Simpson Strong-tie

115
Tmeic

115
UTI

115
Singular Genomics… ◀

115
Abbyy Development

114
Asana

114

What this shows Singular holds 115 patents at rank #3,267, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Singular

By rank, the assignees closest to #3,267 in granted patent volume.

Leaders in C12Q (Measuring OR Testing Processes Involving Enzymes)

Other assignees with the most granted patents in Singular's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Singular, neither rank-band nor same-CPC leaders (those blocks stay above). In C12Q (Measuring OR Testing Processes Involving Enzymes), Singular ranks #55 of 2,502 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (66 here).

Arista Networks, Inc. 66 Philip Morris Products S.A. 66 University of Virginia Patent Foundation 66 Carl Zeiss SMT GmbH 66

Similar claim depth

Nearest assignees by average claims per patent (19.6 here).

Huawei Technologies Canada Co., Ltd. 19.6 avg Knowles Electronics, LLC 19.6 avg Dropbox, Inc. 19.6 avg Strong Force TP Portfolio 2022, LLC 19.6 avg

Singular's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

66 Top 1% higher than 99% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2020–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.

View data table

Singular Genomics Systems, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2020	2	1.7%
2021	5	4.3%
2022	15	13.0%
2023	25	21.7%
2024	41	35.7%
2025partial year	27	23.5%

Which technologies does Singular Genomics Systems, Inc. patent most?

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 75

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 29

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 19

B01L - Chemical OR Physical Laboratory Apparatus FOR General USE 18

C07H - SUGARS; Derivatives THEREOF; NUCLEOSIDES; NUCLEOTIDES; Nucleic Acids 16

C12Y - Enzymes 12

G02B - Optical Elements, Systems OR Apparatus 9

C07F - Acyclic, Carbocyclic OR Heterocyclic Compounds Containing Elements Other Than Carbon, Hydrogen, Halogen, Oxygen, Nitrogen, Sulfur, Selenium OR Tellurium 8

C09B - Organic Dyes OR Closely-related Compounds FOR Producing Dyes ; , e.g. PIGMENTS; MORDANTS; Lakes 6

C40B - Combinatorial CHEMISTRY; Libraries, e.g. Chemical Libraries 4

H04N - Pictorial Communication, e.g. Television 4

C09K - Materials FOR Miscellaneous Applications, NOT Provided FOR Elsewhere 3

G06V - Image OR Video Recognition OR Understanding 3

A61L - Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES; Materials FOR Bandages, Dressings, Absorbent Pads OR Surgical Articles 3

C12P - Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture 3

Top 15 of 26 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Singular Genomics Systems, Inc.'s patent record in context - here's where to go next.

Singular Genomics Systems, Inc.'s lead technology class is C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr), 65.2% of its portfolio - see every assignee active in that class. Explore C12Q
Ranked #3,267 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Singular Genomics Systems, Inc. against Omron Automotive Electronics Co., Ltd., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 66.2/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.